{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:32:38Z","timestamp":1778099558635,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejpb.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T04:59:09Z","timestamp":1471928349000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Film-forming formulations containing porous silica for the sustained delivery of actives to the skin"],"prefix":"10.1016","volume":"108","author":[{"given":"Rouven","family":"Heck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique J.","family":"Lunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.08.010_b0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2005.10.023","article-title":"Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod","volume":"307","author":"Donnelly","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2008.11.015","article-title":"Plasticizers in the manufacture of novel skin-bioadhesive patches","volume":"370","author":"Gal","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejps.2005.10.009","article-title":"Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions","volume":"27","author":"McCarron","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.08.010_b0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0168-3659(00)00365-5","article-title":"Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion","volume":"70","author":"Repka","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.08.010_b0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2009.05.017","article-title":"Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol","volume":"377","author":"Gao","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0939-6411(01)00193-X","article-title":"Self-adhesive thin films for topical delivery of 5-aminolevulinic acid","volume":"53","author":"Lieb","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0040","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.lfs.2006.05.002","article-title":"Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies","volume":"79","author":"Mutalik","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2016.08.010_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/ajem.2002.29562","article-title":"Transdermal fentanyl abuse and misuse","volume":"20","author":"Arvanitis","year":"2002","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejpb.2016.08.010_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2146\/ajhp110158","article-title":"Practical considerations for optimal transdermal drug delivery","volume":"69","author":"Durand","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0055","first-page":"43","article-title":"Plasma concentrations following application of whole versus cut transdermal clonidine patches to critically Ill children","volume":"9","author":"Zuppa","year":"2004","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ejpb.2016.08.010_b0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-3659(03)00015-4","article-title":"Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior","volume":"88","author":"Padula","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.08.010_b0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejpb.2006.11.014","article-title":"Single-layer transdermal film containing lidocaine: modulation of drug release","volume":"66","author":"Padula","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0070","first-page":"CD007393","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","volume":"2","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejpb.2016.08.010_b0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/tde.10.16","article-title":"Challenges and opportunities in dermal\/transdermal delivery","volume":"1","author":"Paudel","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2016.08.010_b0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000348464","article-title":"In vitro skin permeation and penetration of nonivamide from novel film-forming emulsions","volume":"26","author":"Lunter","year":"2013","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2012.06.010","article-title":"New film forming emulsions containing Eudragit(R) NE and\/or RS 30D for sustained dermal delivery of nonivamide","volume":"82","author":"Lunter","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0090","first-page":"14","article-title":"Porous silica gel: an ideal solid hydrophilic carrier for oils and other liquids","volume":"10","author":"Gupta","year":"2012","journal-title":"Tablets Capsules"},{"key":"10.1016\/j.ejpb.2016.08.010_b0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000319862","article-title":"Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730","volume":"221","author":"Stander","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.ejpb.2016.08.010_b0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0190-9622(93)70208-B","article-title":"A double-blind evaluation of topical capsaicin in pruritic psoriasis","volume":"29","author":"Ellis","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","article-title":"Treatment of prurigo nodularis with topical capsaicin","volume":"44","author":"Stander","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0110","first-page":"1049","article-title":"Magistral formulations and pruritus therapy - what is established, what is confirmed, what is new?","volume":"11","author":"Staubach","year":"2013","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"Suppl. 4","key":"10.1016\/j.ejpb.2016.08.010_b0115","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08005.x","article-title":"S2k guideline\u2013Chronic Pruritus","volume":"10","author":"Stander","year":"2012","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.ejpb.2016.08.010_b0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrn1950","article-title":"The neurobiology of itch","volume":"7","author":"Ikoma","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejpb.2016.08.010_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5173(95)04367-5","article-title":"Percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from gel and ointment bases: in vitro formulation evaluations in pigs and in vivo bioengineering methods in humans","volume":"130","author":"Fang","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5173(98)00301-9","article-title":"Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers","volume":"176","author":"Fang","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch","volume":"107","author":"Anand","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejpb.2016.08.010_b0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00105-016-3827-x","article-title":"Extemporaneous magistral formulas for the topical treatment of pruritus: Proven and new options","volume":"67","author":"Staubach","year":"2016","journal-title":"Hautarzt"},{"key":"10.1016\/j.ejpb.2016.08.010_b0145","unstructured":"Hydrophile Capsaicinoid Creme 0.025%\/0.05%\/0.1% (NRF 11.125), in: Neues Rezeptur Formularium, Govi Verlag, D-Eschborn; 2014."},{"key":"10.1016\/j.ejpb.2016.08.010_b0150","unstructured":"Standard Test Method for Oil Absorption of Pigments by Spatula Rub-out, in: D281-95, ASTM International, West Conshohocken, PA, 1995."},{"key":"10.1016\/j.ejpb.2016.08.010_b0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2004.11.004","article-title":"Quantification of the leaching of triethyl citrate\/polysorbate 80 mixtures from Eudragit RS films by differential scanning calorimetry","volume":"60","author":"Gruetzmann","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0846.2006.00179.x","article-title":"Porcine ear skin: an in vitro model for human skin","volume":"13","author":"Jacobi","year":"2007","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0165","first-page":"1","article-title":"Methods for the determination of the substantivity of topical formulations","volume":"1\u20135","author":"Herrmann","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1523-1747.2003.12083.x","article-title":"Bovine-serum-albumin-containing receptor phase better predicts transdermal absorption parameters for lipophilic compounds","volume":"120","author":"Cross","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/js950484a","article-title":"Percutaneous absorption of vanilloids: in vivo and in vitro studies","volume":"86","author":"Kasting","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.08.010_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1382-6689(00)00035-1","article-title":"Percutaneous penetration studies for risk assessment","volume":"8","author":"Sartorelli","year":"2000","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.08.010_b0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jps.2600501018","article-title":"Rate of release of medicaments from ointment bases containing drugs in suspension","volume":"50","author":"Higuchi","year":"1961","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.08.010_b0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijpharm.2003.09.037","article-title":"Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion","volume":"269","author":"Crowley","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2010.10.037","article-title":"Elaborations on the Higuchi model for drug delivery","volume":"418","author":"Paul","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.010_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5173(85)90031-6","article-title":"Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices","volume":"24","author":"Ford","year":"1985","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116304544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116304544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T22:51:17Z","timestamp":1536447077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116304544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0939641116304544"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.08.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Film-forming formulations containing porous silica for the sustained delivery of actives to the skin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}